cbdMD (YCBD) Income from Non-Controlling Interests (2018 - 2019)
cbdMD's (YCBD) quarterly Income from Non-Controlling Interests came in at $712068.0 in Q3 2019, up 147.35% quarter-over-quarter from -$1.5 million in Q2 2019.
cbdMD (YCBD) Income from Non-Controlling Interests (2018 - 2019) Analysis & Trends
cbdMD has disclosed Income from Non-Controlling Interests across 2 years of filings, most recently posting $712068.0 for Q3 2019.
- Income from Non-Controlling Interests for Q3 2019 came in at $712068.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2020 was $712068.0 (changed N/A YoY), and the FY2019 annual result was -$929323.0, down 295.68% from the prior year.
- Income from Non-Controlling Interests came in at $712068.0 for Q3 2019 at cbdMD, up from -$1.5 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $712068.0 in Q3 2019 to a low of -$1.5 million in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 22.56 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | cbdMD | 3,884.57 | -3.38 Mn | 3.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 712,068.00 |
| Jun 30, 2019 | -1.50 Mn |
| Mar 31, 2019 | -58,536.00 |
| Dec 31, 2018 | -79,149.00 |